SCHEMBL30539557

SCHEMBL30539557

Cn1c(=O)c(C(=O)NCc2ccc(C#N)cc2)cc2ccnc(F)c21

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ AKR1B1 P15121 1/20 0.43
▸ CNR1 P21554 2/20 0.43
▸ KLKB1 P03952 1/20 0.43
▸ KLK1 P06870 1/20 0.43
▸ EPHX2 P34913 1/20 0.41
▸ ABCB1 P08183 1/20 0.41
▸ CNR2 P34972 6/20 0.40
▸ ELANE P08246 2/20 0.40
▸ MMP2 P08253 1/20 0.39
▸ MMP3 P08254 1/20 0.39
▸ STAT3 P40763 1/20 0.38
▸ ROCK2 O75116 1/20 0.38
▸ VNN1 O95497 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25348145 1.00 AKR1B1 (0.43) AKR1B1CNR1KLKB1KLK1EPHX2
SCHEMBL30539556 0.88 AKR1B1 (0.48) AKR1B1CNR1KLKB1KLK1EPHX2
SCHEMBL25346972 0.88 AKR1B1 (0.48) AKR1B1CNR1KLKB1KLK1EPHX2
SCHEMBL30539678 0.85 AKR1B1 (0.44) AKR1B1CNR1KLKB1KLK1EPHX2
SCHEMBL25348421 0.85 AKR1B1 (0.44) AKR1B1CNR1KLKB1KLK1EPHX2
SCHEMBL30539591 0.83 MAPK8 (0.44) AKR1B1CNR1KLKB1KLK1EPHX2
SCHEMBL25984911 0.80 CNR2 (0.37) AKR1B1CNR1KLKB1KLK1ABCB1
SCHEMBL25976795 0.79 CNR2 (0.39) AKR1B1KLKB1KLK1EPHX2ABCB1
SCHEMBL25991776 0.79 CNR2 (0.39) AKR1B1KLKB1KLK1ABCB1CNR2
SCHEMBL25991692 0.79 AKR1B1 (0.37) AKR1B1KLKB1KLK1ABCB1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4479388-A1 ANTIVIRAL NAPHTHYRIDINONE COMPOUNDS Gilead Sciences, Inc. (US) 2024-12-25 — — EP disclosed
WO-2023154905-A1 ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS GILEAD SCIENCES, INC. (US) 2023-08-17 — — WO disclosed
Send feedback